Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times
J. Michael Pearson - Wikipedia
What the Average Short Position in Valeant
Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham Transactions
What the Average Short Position in Valeant
Leerverkäufer : Andrew Left - der Mann, vor dem die Wall Street zittert | tagesschau.de
Die Shortsellerin, die schon 2018 gegen Wirecard wettete - Capital.de
The Valeant saga: Why the world needs short sellers
US-Pharmakonzern Valeant: Dieser Skandal könnte Bill Ackman Milliarden und den Ruf kosten - manager magazin
Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete | LGT
The 'Short' Who Sank Valeant Stock - WSJ
Valeant 'short' smells smoke — even when there's no fire
Opinion: Time to short Valeant bonds, go long its stock - MarketWatch
Drug Short - Watch Free Online
Valeant Plunges 30% After Short Seller Citron Research Makes Fraud Allegation
The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor
Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg
Drug Short - Watch Free Online
Valeant shares plunge after 'fraud' accusation from short-seller | CBC News
Short-Seller Chanos Turns Attention to Valeant - The New York Times
Wirecard-Shortsellerin Fahmi Quadir: „Tesla ist aus vielen Gründen attraktiv für Shortseller“
Andrew Left, owner and founder of Citron Research, stands for a... Nachrichtenfoto - Getty Images
The rise and fall of Valeant Pharmaceuticals | CBC News
Valeant Pharmaceuticals Cuts Earnings and Sales Forecasts - The New York Times
Famed short-seller Chanos can't cash in on Valeant
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
Safkhet Capital's Quadir Is Still Short Valeant - YouTube
